Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study
Authors:
- H. SungHSH. Sung
- J. FerlayJFJ. Ferlay
- R.L. SiegelRSR.L. Siegel
- M. LaversanneMLM. Laversanne
- I. SoerjomataramISI. Soerjomataram
- A. JemalAJA. Jemal
- Et Al.EAEt Al.
Open Access
- 7 July 2023
- journal article
- research article
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 46 (4) , 366-373
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research NetworkBMC Hematology, 2013
- Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemiaBlood, 2013
- Planning cancer control in Latin America and the CaribbeanThe Lancet Oncology, 2013
- Treatment advances have not improved the early death rate in acute promyelocytic leukemiaHaematologica, 2011
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNetBlood, 2009
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsBlood, 2009
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2004
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- The burden and outcomes associated with four leukemias: AML, ALL, CLL and CMLExpert Review of Anticancer Therapy, 2003
- Clinical and social factors that affect the time to diagnosis of Mexican children with cancerMedical and Pediatric Oncology, 2002